Peregrine Pharmaceuticals shares owned by Catamount Wealth Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Catamount Wealth Management
from 13F filings
Historical chart of Catamount Wealth Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Catamount Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Catamount Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2019-03-31 | $351k | 83k | 4.25 |
| 2018-12-31 | $318k | 83k | 3.85 |
| 2018-09-30 | $566k | 83k | 6.85 |
| 2018-06-30 | $471k | 83k | 5.70 |
| 2018-03-31 | $300k | 103k | 2.92 |
More positions owned by Catamount Wealth Management
View all positions for Catamount Wealth Management